The inducement of physical, chemical, structural and biological properties to entice of pharmaceutical property was analyzed by Vibrational spectroscopic, biological and theoretical tools. The structural arrangement for describing structure activity was investigated by injecting ligand groups in internal coordinate system by molecular tools (FT adopted IR, Raman, and NMR). Bond length and bond angle strain was pronounced much due to the chemical equivalent forces extension due to the injection of substitutional groups on base compound and thus non-Centro symmetry was processed. The molecular charge depletion profile was thoroughly studied to persuade protonic and electronic delocalization setup for arranging the drug potential. The chemi-equivalent potential exchange was monitored among different parts of the molecule for obtaining drug mechanism. The biological profile was keenly observed to look at the biological ambiance of the present molecule to fabricate advanced drug. The Lipinski five rule parameters; M_V = 137.18, LogP = 0.27, HBD = 2, HBA = 2 and TPSA = 46.2 A² showed the enhancement of additive drug quality. The exchange of oscillating chemical energy in the core and allied carbons of the base skeleton was keenly noted to find the prearranged chemical environment for successful drug mechanism. The non bonded transitions between Lewis acid and base of bonded molecular system were observed to determine the restoring potential to customize drug potential. The drug assistance for enantiomer characteristics of chirality sequence was displayed to expose the toxicity effect of the molecule. The active molecular bondings on different sites of molecule were measured by estimating polarizability and associated biological inhibition was validated.

利用振动光谱、生物学和理论工具分析了物理、化学、结构和生物学特性对药物特性的诱导作用。通过分子工具（FT采用IR、拉曼和NMR）在内坐标系中注入配体基团来研究描述结构活性的结构排列。由于在基础化合物上注入取代基导致化学当量力延伸，键长和键角应变非常明显，因此处理了非中心对称性。彻底研究了分子电荷耗尽曲线，以说服质子和电子离域设置来安排药物潜力。监测分子不同部分之间的化学等价电位交换以获得药物机制。敏锐地观察生物学概况，以了解本分子的生物学环境，以制造先进的药物。Lipinski五规则参数；MV = _137.18，LogP = 0.27，HBD = 2，HBA = 2，TPSA = 46.2 A ²表明附加药物质量的增强。敏锐地注意到核心和基础骨架的相关碳中振荡化学能的交换，以找到成功药物机制的预先安排的化学环境。观察键合分子系统的路易斯酸和碱之间的非键合转变，以确定定制药物电位的恢复电位。展示了手性序列对映体特征的药物辅助，以揭示该分子的毒性作用。通过估计极化率来测量分子不同位点上的活性分子键，并验证相关的生物抑制。